Evidence map›Paper›PMID 17362934›Full record

ArticleExperimental neurology2007

Neurokinins enhance excitability in capsaicin-responsive DRG neurons.

Adrian Sculptoreanu, William C de Groat

Open access · greenAbstract readComparative Study
In one paragraph

Article in Experimental neurology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Responsiveness of afferent renal nerve units in renovascular hypertension in rats.Pflugers Archiv : European journal of physiology · 2021
    Article
  5. Studying human nociceptors: from fundamentals to clinic.Brain : a journal of neurology · 2021
    Review
  6. Article
  7. Article
  8. A-Type KFrontiers in molecular neuroscience · 2018
    Review
  9. Review
  10. Article
  11. Article
  12. Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  13. Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder.International journal of urology : official journal of the Japanese Urological Association · 2013
    Review
  14. Article
  15. Reactive oxygen species are second messengers of neurokinin signaling in peripheral sensory neurons.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  16. An antinociceptive role for substance P in acid-induced chronic muscle pain.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adrian SculptoreanuUniversity of Pittsburgh, School of Medicine, Department of Pharmacology, E1304 Biomedical Science Tower, Pittsburgh, PA 15261, USA. ads5@pitt.edu <ads5@pitt.edu>
William C de Groat
University of Pittsburgh · US

Funding

AFFERENT MECHANISMS UNDERLYING BLADDER PAINR37DK049430 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEGROAT, WILLIAM C · 2000 to 2009
$3.0M
NIDDK NIH HHS R37 DK049430
6 · The paper itself

Abstract

Neurokinins released by capsaicin-responsive (C-R) dorsal root ganglia neurons (DRG) may control firing in these neurons by an autofeedback mechanism. Here we used patch clamp techniques to examine the effects of neurokinins on firing properties of dissociated DRG neurons of male rats. In C-R neurons that generated only a few action potentials (APs, termed phasic) in response to long depolarizing current pulses (600 ms), substance P (SP, 0.5 microM) lowered the AP threshold by 11.0+/-0.3 mV and increased firing from 1.1+/-0.7 APs to 5.2+/-0.6 APs. In C-R tonic neurons that fire multiple APs, SP elicited smaller changes in AP threshold (6.0+/-0.1 mV reduction) and the number of APs (11+/-1 vs. 9+/-1 in control). The effects of SP were similar to the effect of heteropodatoxin II (0.05 microM) or low concentrations of 4-aminopyridine (50 microM) that block A-type K(+) currents. A selective NK(2) agonist, [betaAla(8)]-neurokinin A (4-10) (0.5 microM), mimicked the effects of SP. The effects of SP in C-R phasic neurons were fully reversed by an NK(2) receptor antagonist (MEN10376, 0.5 microM) but only partially by a protein kinase C (PKC) inhibitor (bisindolylmaleimide, 0.5 microM). An NK(3)-selective agonist ([MePhe(7)]-neurokinin B, 0.5 microM), an NK(1)-selective agonist ([Sar(9), Met(11)]-substance P, 0.5 microM) or activation of PKC with phorbol 12,13-dibutyrate (0.5 microM) did not change firing. Our data suggest that the excitability of C-R phasic afferent neurons is increased by activation of NK(2) receptors and intracellular signaling mediated only in part by PKC.

Indexed as

Action PotentialsAnimalsCapsaicinElectric StimulationEnzyme ActivationGanglia, SpinalIntracellular MembranesMaleNeurokinin ANeurons, AfferentPatch-Clamp TechniquesPeptide FragmentsPotassium Channel BlockersPotassium ChannelsProtein Kinase CProtein Kinase InhibitorsCapsaicinNeurokinin Aneurokinin A (4-10), beta-Ala(8)-neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)-Peptide FragmentsPotassium Channel BlockersPotassium ChannelsProtein Kinase CProtein Kinase InhibitorsReceptors, Neurokinin-2Substance PTachykinins

Identifiers

PMID17362934
PMCPMC1995809
OpenAlexW2032797890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.